Article
Genetic Evidence for a Novel Glutamatergic Augmentation in Treatment-Resistant OCD: CREB1 as a Key Driver of Impaired Plasticity
2025-12-24
Abstract excerpt
<h4>Background: </h4> A large proportion of people with obsessive–compulsive disorder (OCD) – roughly 40–60 % even after carefully optimised treatment – do not improve enough with selective serotonin re-uptake inhibitors (SSRIs). Small naturalistic series have suggested that the Cheung Glutamatergic Regimen (CGR), an inexpensive oral combination of dextromethorphan, fluoxetine and piracetam, can ease symptoms quic...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- c8d22205-d3f1-51fb-b796-f27ae71b3632
- DOI
- 10.20944/preprints202512.2104.v1
